Previous close | 1.8000 |
Open | 2.4000 |
Bid | 0.0000 |
Ask | 5.7000 |
Strike | 420.00 |
Expiry date | 2023-10-20 |
Day's range | 1.8000 - 2.4000 |
Contract range | N/A |
Volume | |
Open interest | 3 |
GE Healthcare's potential windfall from Leqembi approval is being hampered by CMS coverage of PET scans.
With its stock down 14% over the past three months, it is easy to disregard Biogen (NASDAQ:BIIB). But if you pay close...
In the latest trading session, Biogen Inc. (BIIB) closed at $258.44, marking a -0.19% move from the previous day.